UK markets closed

Arbutus Biopharma Corporation (I9DN.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.4540-0.1220 (-4.74%)
At close: 08:06AM CEST
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts5555
Avg. Estimate-0.24-0.22-0.9-0.79
Low estimate-0.25-0.24-0.93-1.02
High estimate-0.23-0.19-0.85-0.61
Year ago EPS-0.27-0.23-1-0.9
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts5544
Avg. Estimate2.38M2.64M9.57M12.58M
Low estimate2.1M2.3M8.8M9.3M
High estimate2.8M3.8M11M16.4M
Year ago salesN/A2.39M6.91M9.57M
Sales growth (year/est)N/A10.60%38.40%31.50%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-0.22-0.22-0.23-0.22
Actual EPS-0.27-0.23-0.21-0.23
Difference-0.05-0.010.02-0.01
Surprise %-22.70%-4.50%8.70%-4.50%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.24-0.22-0.9-0.79
7 days ago-0.24-0.22-0.9-0.79
30 days ago-0.24-0.22-0.9-0.79
60 days ago-0.23-0.22-0.89-0.76
90 days ago-0.23-0.22-0.89-0.76
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesI9DN.FIndustrySector(s)S&P 500
Current qtr.11.10%N/AN/AN/A
Next qtr.4.30%N/AN/AN/A
Current year10.00%N/AN/AN/A
Next year12.20%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A